Ovidrel Syringe 250 microgram Drug Use-Results Survey
Not Applicable
- Conditions
- - Ovulation induction and luteinization in infertile patients with oligo- or anovulation due to a dysfunction in hypothalamic-pituitary system - Final follicle maturation and early luteinization in Assisted Reproductive Technologies
- Registration Number
- JPRN-UMIN000036930
- Lead Sponsor
- Merck Biopharma Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 419
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with contraindications in the package insert.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of adverse drug reactions and infections, the incidence of serious adverse events, and so on
- Secondary Outcome Measures
Name Time Method